Publicaciones en colaboración con investigadores/as de Hospital de Cabueñes (17)

2024

  1. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

2022

  1. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 8

  2. Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 9

  3. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease

    Current Alzheimer research, Vol. 18, Núm. 9, pp. 695-700

2020

  1. Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer's disease

    Analytica Chimica Acta, Vol. 1093, pp. 28-34

2019

  1. Desertomycin G, a new antibiotic with activity against mycobacterium tuberculosis and human breast tumor cell lines produced by streptomyces althioticus MSM3, isolated from the cantabrian sea intertidal macroalgae ulva sp.

    Marine Drugs, Vol. 17, Núm. 2

  2. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

    Frontiers in Immunology, Vol. 10

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

2016

  1. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 7, pp. 532-541

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

2012

  1. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: Association with soluble MICA shedding

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 8, pp. 1201-1210

2008

  1. Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk

    BMC Cancer, Vol. 8

2007

  1. Influencia de los polimorfismos en genes de metabolización de carcinógenos y riesgo de cáncer de pulmón

    Mapfre Medicina, Vol. 18, Núm. 4, pp. 292-304

  2. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain

    BMC Cancer, Vol. 7

2003

  1. IL-1α (-889) promoter polymorphism is a risk factor for osteomyelitis

    American Journal of Medical Genetics, Vol. 119 A, Núm. 2, pp. 132-136